CMS proposes changes to increase Medicaid drug price transparency
The Centers for Medicare & Medicaid Services this week proposed changes to the Medicaid Drug Rebate Program intended to improve manufacturer data integrity and help states verify drug prices. CMS will accept comments on the proposed rule through July 25.
Related News Articles
Headline
The House committees with jurisdiction over Medicaid and other health care programs have announced they will begin marking up their portions of the budget…
Headline
Freshman Sens. Elissa Slotkin, D-Mich., and Ruben Gallego, D-Ariz., May 6 joined former CNN correspondent Frank Sesno at the 2025 AHA Annual Membership Meeting…
Headline
Rep. Nathaniel Moran, R-Texas, and Rep. Brad Schneider, D-Ill., both members of the House Ways and Means Committee, spoke to the AHA Annual Membership Meeting…
Headline
Rep. Mariannette Miller-Meeks, R-Iowa, participated in a fireside chat during the afternoon plenary session May 5 at the 2025 AHA Annual Membership meeting. As…
Headline
Rep. Robin Kelly, D-Ill., member of the Health Subcommittee of the Energy and Commerce Committee and chair of the Congressional Black Caucus Health Braintrust…
Headline
The AHA has released several resources that can be used to educate members of Congress and community stakeholders about the potential effects of harmful cuts…